|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.620 USD | +4.66% |
|
+6.64% | -57.54% |
| 06-14 | Fibrogen Inc - On June 12 Enters Termination, Asset Transfer And License Agreement With Hifibio | RE |
| 06-13 | FibroGen to Implement 1-for-25 Reverse Stock Split | MT |
| Capitalization | 22.71M 19.4M 18.11M 16.75M 31.08M 1.95B 34.82M 217M 82.35M 909M 85.19M 83.44M 3.33B | P/E ratio 2025 * |
-0.46x | P/E ratio 2026 * | -0.31x |
|---|---|---|---|---|---|
| Enterprise value | 22.71M 19.4M 18.11M 16.75M 31.08M 1.95B 34.82M 217M 82.35M 909M 85.19M 83.44M 3.33B | EV / Sales 2025 * |
2.27x | EV / Sales 2026 * | 2.37x |
| Free-Float |
99.16% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: FibroGen, Inc.
More recommendations
More press releases
More news
| 1 day | +4.66% | ||
| 1 week | +6.64% | ||
| Current month | +6.04% | ||
| 1 month | -28.25% | ||
| 3 months | -10.86% | ||
| 6 months | -65.46% | ||
| Current year | -57.54% |
| 1 week | 5.37 |  | 5.73 |
| 1 month | 4.85 | | 8.12 |
| Current year | 4.85 | | 21.94 |
| 1 year | 4.5 | | 38.25 |
| 3 years | 4.5 | | 642.25 |
| 5 years | 4.5 | | 1,430.22 |
| 10 years | 4.5 | | 1,713.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thane Wettig
CEO | Chief Executive Officer | 60 | 23/07/2023 |
David DeLucia
DFI | Director of Finance/CFO | 36 | 16/12/2024 |
Elias Kouchakji
CTO | Chief Tech/Sci/R&D Officer | 68 | 01/01/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
James Schoeneck
CHM | Chairman | 67 | 06/01/2020 |
Jeffrey Edwards
BRD | Director/Board Member | 64 | 28/10/2015 |
May Kin Ho
BRD | Director/Board Member | 72 | 06/12/2018 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 3.83% | 1 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.66% | +6.64% | -72.22% | -98.18% | 22.71M | ||
| -0.82% | -3.20% | +14.76% | +32.12% | 33.25B | ||
| +0.80% | -0.42% | +90.94% | -36.12% | 28.1B | ||
| +1.46% | +3.86% | +38.73% | -34.37% | 27.49B | ||
| -0.84% | -1.52% | +37.24% | +287.66% | 18.26B | ||
| +1.68% | +8.44% | +204.50% | +2,153.92% | 17.07B | ||
| +0.58% | +0.78% | +139.80% | -67.69% | 13.32B | ||
| +0.55% | +4.18% | -22.08% | -45.09% | 13.16B | ||
| -0.46% | +17.67% | +197.95% | +344.81% | 12.55B | ||
| -1.47% | -0.25% | +96.97% | +97.68% | 11.87B | ||
| Average | +0.37% | +3.84% | +72.66% | +263.48% | 17.51B | |
| Weighted average by Cap. | -0.00% | +2.53% | +77.03% | +257.73% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 10M 8.54M 7.97M 7.37M 13.68M 858M 15.33M 95.52M 36.25M 400M 37.5M 36.73M 1.47B | 9.6M 8.2M 7.65M 7.08M 13.14M 824M 14.72M 91.7M 34.8M 384M 36M 35.26M 1.41B |
| Net income | -49.55M -42.32M -39.5M -36.53M -67.8M -4.25B -75.96M -473M -180M -1.98B -186M -182M -7.27B | -84.9M -72.51M -67.68M -62.59M -116M -7.28B -130M -811M -308M -3.4B -318M -312M -12.46B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
225
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/07/25 | 5.620 $ | +4.66% | 29,113 |
| 07/07/25 | 5.370 $ | -4.28% | 37,302 |
| 03/07/25 | 5.610 $ | +6.86% | 33,072 |
| 02/07/25 | 5.250 $ | -0.38% | 75,023 |
| 01/07/25 | 5.270 $ | -0.57% | 20,966 |
Delayed Quote Nasdaq, July 09, 2025 at 04:00 am
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
5.620USD
Average target price
250.00USD
Spread / Average Target
+4,348.40%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- FGEN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition